Work

A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: A Southwest Oncology Group study

Year: 2006

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-006-8440-x

Authors: Robert P. Whitehead, Sheryl McCoy, Saul E. Rivkin, Howard M. Gross, Marcel E. Conrad, Gary C. Doolittle, Robert A. Wolff, J. Wendall Goodwin, Shaker R. Dakhil, James L. Abbruzzese

Institutions: The University of Texas Medical Branch at Galveston, SWOG Cancer Research Network, Dayton Clinical Oncology Program, University of Kansas Medical Center, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group, Greenville SC CCOP, WESTERN ONCOLOGY RESEARCH CONSORTIUM, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, MICHIGAN CANCER RESEARCH CONSORTIUM CCOP, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3618815874, City of Hope Southwest Oncology Group Clinical Trials, Dayton Clinical Oncology Program, SOUTHWEST ONCOLOGY GROUP--CLINICAL TRIALS, Southwest Oncology Group, Southwest Oncology Group, SOUTHWEST ONCOLOGY GROUP, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, Southwest Oncology Group Treatment Grant, Southwest Oncology Group, Gulf Coast MBCCOP, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, SOUTHWEST ONCOLOGY GROUP STUDIES, NORTHWEST COMMUNITY CLINICAL ONCOLOGY PROGRAM, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, G763325562, Kansas City Clincal Oncology Program CCOP, PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP, Southwest Oncology Group/University of California, Davis

OpenAlex ID: W1981120731

FWCI: 8.37

Cites: 17

Cited by: 73

Related to: 10